Delivery Order SPE2DB20D2014-SPE2DB24FC58V
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,553.36, is for the delivery of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a pharmaceutical product, with a performance period through March 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a $26,744.35 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The award is for the supply of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a medical product used in healthcare. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor and there are no reported subcontractors. This delivery order is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Fulphila 6 mg/0.6 ml syringes. The $25,707.13 firm-fixed-price delivery order has an ultimate completion date of August 15, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fulphila 6 mg/0.6 mL syringes. The $11,674.80 firm fixed-price delivery order has a completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fulphila 6 mg/0.6 ml syringes. The contract has a firm fixed price of $1,006.88 and a completion date of June 5, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which...
This federal contract award is for the delivery of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,316.27 and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a performance period through May 10, 2024 and is a firm fixed-price arrangement. There is no set-aside designation for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,097.53 firm-fixed price delivery order is for the supply of 4566293391 FULVESTRANT 250 MG/5 ML SYRING 5ML, a specialty pharmaceutical product, with an ultimate completion date of November 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test...
This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mls to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order, valued at $8,599.36, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 30, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally....